Format

Send to

Choose Destination
Blood Adv. 2018 Jan 23;2(2):142-145. doi: 10.1182/bloodadvances.2017012047.

Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis.

Author information

1
Division of Hematology/Oncology, Department of Pediatrics, and.
2
Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX.
PMID:
29365322
PMCID:
PMC5787863
DOI:
10.1182/bloodadvances.2017012047
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center